Disposition and metabolism of cabotegravir: a comparison of biotransformation and excretion between different species and routes of administration in humans-Reference-Cited by-同舟云学术

Disposition and metabolism of cabotegravir: a comparison of biotransformation and excretion between different species and routes of administration in humans

Published:2015-07 Issue:2 Volume:46 Page:147-162
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Bowers Gary David,Culp Amanda,Reese Melinda J.,Tabolt Glenn,Moss Lee,Piscitelli Stephen,Huynh Phuong,Wagner David,Ford Susan L.,Gould Elizabeth P.,Pan Rennan,Lou Yu,Margolis David A.,Spreen William R.

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/00498254.2015.1060372

Reference22 articles.

1. Minimal Pharmacokinetic Interaction between the Human Immunodeficiency Virus Nonnucleoside Reverse Transcriptase Inhibitor Etravirine and the Integrase Inhibitor Raltegravir in Healthy Subjects

2. Long-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus

3. Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans

4. Limits for qualitative detection and quantitative determination. Application to radiochemistry

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07

2. Clinical pharmacology considerations and drug–drug interactions with long‐acting cabotegravir and rilpivirine relevant to sub‐Saharan Africa;British Journal of Clinical Pharmacology;2024-06-25

3. HIV Pre-Exposure Prophylaxis: New and Upcoming Drugs to Address the HIV Epidemic;Drugs;2023-12

4. Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016–2022);Pharmaceuticals;2023-08-15

5. Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance;Pharmacology & Therapeutics;2023-08